Previous Chapter: Interim Report
Suggested Citation: "Appendix A Methods." Institute of Medicine. 2005. Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/11191.

Appendix A
Methods

The committee developed this interim report and arrived at preliminary conclusions about the strengths and weaknesses of the BCPR during a five-month period from April 2004 to September 2004. During this time, the committee held three data-gathering sessions and met in closed session three times to deliberate. Agendas for the open, data-gathering sessions of these meetings are included in this appendix. The committee’s final report will provide a full list of meeting participants and contributors to the study process.

Suggested Citation: "Appendix A Methods." Institute of Medicine. 2005. Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/11191.

INSTITUTE OF MEDICINE

AGENDA

Committee on Aerospace Medicine and Medicine in Extreme Environments

and

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

Keck Building

500 5th Street, NW

Washington, DC

Room 110

MONDAY, APRIL 12, 2004

CLOSED SESSION (committee and staff only)

8:00 a.m. – 12:00 p.m.

OPEN SESSION

12:00 p.m.

Lunch

1:15 p.m.

Request for a review of the Bioastronautics Critical Path Roadmap

Richard Williams, M.D., Chief Health and Medical Officer, NASA

2:00 p.m.

Overview of the Bioastronautics Critical Path Roadmap

NASA presenters: Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Howard Ross, Acting Deputy Associate Administrator for Science, Office of Biological and Physical Research; Mark Shepanik, Aerospace Medicine Specialist, NASA; Frank Sulzman, Manager, Space Radiation Health Project

3:00 p.m.

Break

3:30 p.m.

Categories of critical research issues and metrics used in the Bioastronautics Critical Path Roadmap

4:10 p.m.

Efficiency and technology issues in the Bioastronautics Critical Path Roadmap

4:50 p.m.

Plenary discussion

Led by David Longnecker, M.D.

5:30 p.m.

Adjourn to reception and dinner with invited guests

Location: third floor atrium

Suggested Citation: "Appendix A Methods." Institute of Medicine. 2005. Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/11191.

INSTITUTE OF MEDICINE

AGENDA

Committee on Aerospace Medicine and Medicine in Extreme Environments

and

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

Keck Building

500 5th Street, NW

Washington, DC

Room 110

TUESDAY, APRIL 13, 2004

OPEN SESSION

8:00 a.m.

Continental breakfast

8:30 a.m.

Welcoming remarks

David Longnecker, M.D.

8:45 a.m.

Overview of related work by the National Academies

9:00 a.m.

Space Studies Board/Aeronautics and Space Engineering Board

9:30 a.m.

Committee on Aerospace Medicine and Medicine in Extreme Environments

10:00 a.m.

Break

CLOSED SESSION (committee and staff only)

10:15 a.m. – 3:30 p.m.

Suggested Citation: "Appendix A Methods." Institute of Medicine. 2005. Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/11191.

INSTITUTE OF MEDICINE

AGENDA

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

Keck Building

500 5th Street, NW

Washington, DC

Room 204

WEDNESDAY, JUNE 9, 2004

OPEN SESSION

9:00 a.m.

Welcome and overview of day’s agenda

David Longnecker, M.D., and Lisa Vandemark, Ph.D.

9:15 a.m.

Briefings related to the review of the Bioastronautics Critical Path Roadmap

NASA presenters: Lauren Leveton, Bioastronautics Science Management Team, NASA; Holly Patton, Aerospace Technologist, NASA; David Tomko, Lead Scientist, Biomedical Program, NASA Bioastronautics Research Division; Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Frank Sulzman, Manager, Space Radiation Health Project

12:00 p.m.

Lunch

1:00 p.m.

Bone loss and countermeasures: historical perspectives and new in-flight clinical studies

Jay Shapiro, M.D., Uniformed Services University

2:00 p.m

Harmonization of crew living module and extravehicular pressure suit atmospheric constituents and pressures

Bruce McCandless, M.S., M.B.A., Lockheed Martin

3:00 p.m.

Break

3:30 p.m.

An overview of space biology from cells to humans

David Klaus, Ph.D., University of Colorado, Boulder

4:30 p.m.

Plenary discussion

Led by David Longnecker, M.D.

5:30 p.m.

Adjourn

THURSDAY, JUNE 10, 2004

CLOSED SESSION (committee and staff only)

8:30 a.m. – 3:00 p.m.

Suggested Citation: "Appendix A Methods." Institute of Medicine. 2005. Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/11191.

INSTITUTE OF MEDICINE

AGENDA

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

Keck Building

500 5th Street, NW

Washington, DC

Room 201

MONDAY, AUGUST 2, 2004

OPEN SESSION

9:00 a.m.

Welcome, introductions, and overview of day’s agenda

David Longnecker, M.D., and Lisa Vandemark, Ph.D.

9:20 a.m.

Briefings related to the review of the Bioastronautics Critical Path Roadmap

Richard Williams, M.D.

10:30 a.m.

Break

11:00 a.m.

Briefings related to the review of the Bioastronautics Critical Path Roadmap

NASA presenters via videoconference from JSC: Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Mark Shepanik, Aerospace Medicine Specialist, NASA; Desmond Lugg, Chief, Medicine of Extreme Environments, Office of the Chief Medical Officer

11:30 a.m.

Question and answer discussion

David Longnecker, M.D., moderator

12:00 p.m.

Lunch

1:00 p.m.

Advanced life support issues

Brian Dunaway, Boeing Corporation

CLOSED SESSION (committee and staff only)

2:30 p.m. – 5:30 p.m.

TUESDAY, AUGUST 3, 2004

CLOSED SESSION (committee and staff only)

8:30 a.m. – 3:00 p.m.

Suggested Citation: "Appendix A Methods." Institute of Medicine. 2005. Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/11191.
Page 21
Suggested Citation: "Appendix A Methods." Institute of Medicine. 2005. Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/11191.
Page 22
Suggested Citation: "Appendix A Methods." Institute of Medicine. 2005. Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/11191.
Page 23
Suggested Citation: "Appendix A Methods." Institute of Medicine. 2005. Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/11191.
Page 24
Suggested Citation: "Appendix A Methods." Institute of Medicine. 2005. Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/11191.
Page 25
Next Chapter: Appendix B NASA. 2004. Bioastronautics Critical Path Roadmap (BCPR): An Approach to Risk Reduction and Management for Human Space Flight. Houston, TX: Lyndon B. Johnson Space Center
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.